Blue Sail Medical (002382.SZ) released its performance for the first half of the year, with a net loss attributable to shareholders of 135 million yuan, a narrowed decrease of 15.88%.

News from the Securities Times app, Lanfan Medical (002382.SZ) released its 2025 interim report, with the company's operating income at 2.781 billion yuan, a decrease of 7.49% year-on-year. The net loss attributable to shareholders of the listed company was 135 million yuan, down 15.88% year-on-year. The net loss attributable to shareholders of the listed company excluding non-recurring gains and losses was 210 million yuan, an increase of 11.82% year-on-year. Basic loss per share was 0.13 yuan.